ArticleBiologics : targets & therapy2019

New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic.

Marco Caminati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.